PRP Treatment for Shoulder Osteoarthritis
PRP for Glenohumeral Osteoarthritis
Recruiting
Phase 4
Interventional Study
Shoulder Osteoarthritis
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 135 (estimated)
- Sponsor
- Hospital for Special Surgery, New York · Other
Who this trial is looking for
This trial is looking for adults aged 18 to 100 who have shoulder pain from osteoarthritis. Participants will receive one injection of either low-dose PRP, high-dose PRP, or saline to see which is more effective.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 18 and 100 years old.
- I have at least a 5 out of 10 pain score from shoulder osteoarthritis.
- I have had shoulder pain for at least 3 months.
- I have tried physical therapy without success.
- I have had an MRI of my shoulder joint.
- I felt temporary relief from a previous injection into the joint.
- I have an email address or access to the internet.
You may not be able to join if
- I cannot stop taking non-steroidal anti-inflammatory drugs for 2 weeks before and 1 month after the injection.
- I have had a platelet-rich plasma injection before.
- I have received a steroid injection in the last 3 months.
- I have taken hyaluronic acid in the last 6 months.
- I am involved in workers' compensation or a lawsuit regarding my shoulder.
- I have used Plavix.
- I have a known uncontrolled systemic illness.
- I have acute fractures or major deformities in my shoulder.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The glenohumeral joint is the third most common large joint to be affected by OA. Conservative treatments include physical activity, corticosteroid injections, and medications. PRP is an emerging treatment that has shown efficacy in different musculoskeletal conditions. The use of PRP for glenohumeral OA has been described sparingly in the literature but has shown efficacy in a couple studies and …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 18-100 years old
* Average NRS pain greater than or equal to 5/10 as a direct result of glenohumeral osteoarthritis (any severity: mild, moderate, or severe) and/or chondral lesion or loss
* At least 3 months of pain after onset of symptoms that has failed conservative treatme…
Contacts